Page last updated: 2024-08-25

terlipressin and Chronic Disease

terlipressin has been researched along with Chronic Disease in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	3 (50.00)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gow, P; Papaluca, T	1
Alexander, GJ; Srivastava, B	1
Ball, C; Bone, HG; Borgulya, R; Sielenkämper, AW; Stubbe, H; Van Aken, H; Westphal, M	1
Asfar, P	1
Almeida, JA; Bihari, D; Cranney, GB; Galhenage, S; Kim, R; Liu, J; Riordan, SM; Thomas, PS; Wegner, EA	1
Auroux, J; Barbier, JP; Cellier, C; Cervoni, JP; Gadano, A; Landi, B; Lecomte, T; Simon, C	1

Reviews

4 review(s) available for terlipressin and Chronic Disease

Article	Year
Terlipressin: Current and emerging indications in chronic liver disease. Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:3 Topics: Chronic Disease; Humans; Infusions, Intravenous; Liver Circulation; Liver Cirrhosis; Liver Diseases; Lypressin; Portal Pressure; Renal Circulation; Terlipressin	2018
Renal failure in chronic liver disease and the hepatorenal syndrome. British journal of hospital medicine (London, England : 2005), 2011, Volume: 72, Issue:9 Topics: Bilirubin; Chronic Disease; Evidence-Based Practice; Fluid Therapy; Hemodynamics; Hepatorenal Syndrome; Humans; Kidney; Liver; Liver Cirrhosis; Liver Transplantation; Lypressin; Monitoring, Physiologic; Patient Selection; Portasystemic Shunt, Surgical; Regional Blood Flow; Renal Insufficiency; Serum Albumin; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents	2011
Terlipressin in chronic hyperdynamic endotoxic shock: is it safe? Intensive care medicine, 2003, Volume: 29, Issue:2 Topics: Animals; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Lypressin; Oxygen Consumption; Safety; Shock, Septic; Terlipressin; Vasoconstrictor Agents	2003
Terlipressin may influence the outcome of hepatorenal syndrome complicating alcoholic hepatitis. The American journal of gastroenterology, 1997, Volume: 92, Issue:11 Topics: Aged; Chronic Disease; Female; Hepatitis, Alcoholic; Hepatorenal Syndrome; Humans; Lypressin; Remission Induction; Terlipressin	1997

Other Studies

2 other study(ies) available for terlipressin and Chronic Disease

Article	Year
Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive care medicine, 2003, Volume: 29, Issue:2 Topics: Animals; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endotoxemia; Female; Hemodynamics; Infusions, Intravenous; Lypressin; Oxygen Consumption; Prospective Studies; Pulmonary Circulation; Respiratory Transport; Sheep; Shock, Septic; Terlipressin; Typhoid Fever; Vasoconstrictor Agents	2003
Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome. European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:4 Topics: Antihypertensive Agents; Blood Pressure; Chronic Disease; Curcumin; Cyclic GMP; Echocardiography; Female; Hepatopulmonary Syndrome; Humans; Lypressin; Methylene Blue; Middle Aged; Nitric Oxide; Terlipressin; Treatment Failure; Vascular Resistance	2007

Article

Year

Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport.

Intensive care medicine, 2003, Volume: 29, Issue:2

Topics: Animals; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endotoxemia; Female; Hemodynamics; Infusions, Intravenous; Lypressin; Oxygen Consumption; Prospective Studies; Pulmonary Circulation; Respiratory Transport; Sheep; Shock, Septic; Terlipressin; Typhoid Fever; Vasoconstrictor Agents

2003

Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.

European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:4

Topics: Antihypertensive Agents; Blood Pressure; Chronic Disease; Curcumin; Cyclic GMP; Echocardiography; Female; Hepatopulmonary Syndrome; Humans; Lypressin; Methylene Blue; Middle Aged; Nitric Oxide; Terlipressin; Treatment Failure; Vascular Resistance

2007